The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.65
Bid: 6.35
Ask: 7.05
Change: -0.175 (-2.56%)
Spread: 0.70 (11.024%)
Open: 6.30
High: 6.65
Low: 6.30
Prev. Close: 6.825
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brazil approves PHC279 to Control Soybean Rust

5 Jan 2021 15:37

RNS Number : 6638K
Plant Health Care PLC
05 January 2021
 

RNS

5 January 2021

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

Brazil approves PHC279 to Control Asian Soybean Rust: First Product from PREtec Platform Approved for Sale in Brazil

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce its new seed treatment, PHC279, for the prevention and treatment of Asian soybean rust (ASR) has received federal approval for sale in Brazil.

Highlights

· PHC279 is the first product from Plant Health Care's PREtec technology platform ("Vaccines for Plants") approved for sale in Brazil, following $20m invested globally over the last eight years.

· PHC279 has the potential to deliver disease control and yield increase worth approximately US$75/ha for Brazilian soybean growers, giving them an ROI of 6x or more, while reducing the use of potentially less safe agrochemicals.

· PHC279's environmentally friendly profile and unique mode of action is expected to lead to wide adoption by Brazilian soybean growers.

· The Company aims to launch PHC279 during the second half of 2021 and expects to build significant market penetration over the following 2-3 years; gross margins are expected to be comparable to those of current Harpin products.

· PREtec peptides represent a novel class of technology which stimulate the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and is compatible with mainstream agricultural practices.

· Brazil is the world's leading soybean producer with 38.6 million hectares (95.3 million acres) planted in the current season. ASR, caused by the fungus Phakopsora pachyrhizi, is a devastating disease with an estimated crop yield loss of up to 90%. Brazilian soybean farmers spent US$2 billion on fungicides during the 2016/2017 harvest for ASR control. Intensive use of traditional chemical fungicides has resulted in the reduction of efficacy of those products over time, highlighting the need for new, environmentally friendly products such as PHC279.

The regulatory process in Brazil for agricultural products involves detailed review and approval by three government agencies. The Ministry of Agriculture (MAPA) confirms that a product is effective; the National Health Surveillance Agency (ANVISA) checks for safety to humans in use and in food, while the Brazilian Institute of Environment and Renewable Natural Resources (IBAMA) confirms that products do not pose a threat to the environment. While the time required for registration of conventional pesticides can be six years or more, PHC279 passed through this process with approval from all three agencies in one year. This confirms the Brazilian government's commitment to promoting effective and environmentally friendly products.

Chris Richards, CEO of Plant Health Care said, "PHC279 is the first of many products we plan to introduce in Brazil from the Company's PREtec platform. Achieving regulatory approval in Brazil in under 12 months is a strong endorsement of the sustainability credentials of PHC279. We anticipate launching PHC279 for use in the 2021/22 soybean season and the Company is advancing plans to secure distribution partners. Outside Brazil, we are preparing to launch this novel technology directly to markets in the U.S. and other countries, initially targeting markets with an opportunity of $5 billion."

For further information, please contact:

Plant Health Care plc

Chris Richards, CEO, Tel: +1 919 926 1600

 

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900

 

Company website: www.planthealthcare.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REASSDFIIEFSEDF
Date   Source Headline
13th May 200812:41 pmRNSDirectors' dealings and addit
1st May 20082:39 pmRNSAdditional Listing
30th Apr 20086:11 pmRNSAnnual Report and Accounts
30th Apr 200811:24 amRNSTotal Voting Rights
28th Apr 20088:09 amRNSNew Trials
14th Apr 20085:39 pmRNSDirector/PDMR Shareholding
2nd Apr 20086:18 pmRNSDirector/PDMR Shareholding
1st Apr 20087:01 amRNSDirectorate Change
1st Apr 20087:01 amRNSTotal Voting Rights
31st Mar 20087:02 amRNSFinal Results
12th Mar 20084:40 pmRNSAdditional Listing
29th Feb 20084:59 pmRNSTotal Voting Rights
21st Feb 20087:01 amRNSStatement re Monsanto
18th Feb 20088:00 amRNSASA Partnership
12th Feb 20085:14 pmRNSAdditional Listing
31st Jan 20084:03 pmRNSTotal Voting Rights
21st Jan 20087:01 amRNSRe Agreement
21st Jan 20087:01 amRNSProduct Update
21st Jan 20087:01 amRNSTrading Statement
14th Jan 200811:57 amRNSNotification of Shareholding
9th Jan 20089:00 amRNSField Trial Update
31st Dec 200712:51 pmRNSTotal Voting Rights
19th Dec 20079:00 amRNSNotification of Shareholding
3rd Dec 20073:00 pmRNSTotal Voting Rights
20th Nov 20079:15 amRNSAdditional Listing
1st Nov 200712:16 pmRNSTotal Voting Rights
24th Oct 20076:13 pmRNSStock Award
22nd Oct 200710:35 amRNSNotification of Shareholding
5th Oct 20073:56 pmRNSNotification of Shareholding
2nd Oct 20074:46 pmRNSNotification of Shareholding
2nd Oct 200712:59 pmRNSTotal Voting Rights
1st Oct 20075:54 pmRNSNotification of Shareholding
1st Oct 20075:51 pmRNSNotification of Shareholding
1st Oct 20073:22 pmRNSDoc re. Interim Results
27th Sep 20075:19 pmRNSDirector/PDMR Shareholding
27th Sep 20077:01 amRNSPlacing
24th Sep 20077:03 amRNSHalf Year Results
24th Sep 20077:02 amRNSMyconate Trial Results
31st Aug 200710:14 amRNSTotal Voting Rights
28th Aug 20071:00 pmRNSStock Award
23rd Aug 200710:14 amRNSNotice of Results
13th Aug 20074:15 pmRNSAIM Rule 26 Information
13th Aug 200711:55 amRNSHolding(s) in Company
13th Aug 20078:49 amRNSHolding(s) in Company
31st Jul 200711:39 amRNSTotal Voting Rights
27th Jul 20077:01 amRNSN-Hibit Trial Results
25th Jul 20071:38 pmRNSAdditional Listing
23rd Jul 200711:35 amRNSDirector/PDMR Shareholding
2nd Jul 20072:25 pmRNSTotal Voting Rights
27th Jun 20077:01 amRNSProduct Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.